Clinical Trial

The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt

Name: The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt — clinical trial record (NCT07509385)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Study aimsTo measure the serum levels of IL-17 A and IL-10 in newly diagnosed patients with B-cell acute lymphoblastic leukemia (B-ALL). 2-To study the association between serum cytokine levels (IL-17 A and IL-10) and laboratory parameters, as well as the response to treatment

Trial Details

NCT Number	NCT07509385
Lead Sponsor	Assiut University
Conditions	Acute Lymphoblastic Leukemia, B-Cell
Enrollment	80 participants
Start Date	2026-03-31
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-05-29 (estimated)
Updated on ClinicalTrials.gov	2026-04-03